Beck Mack & Oliver LLC Abbott Laboratories Transaction History

Beck Mack & Oliver LLC

$4.44 Billion
Q3 2024

A detailed history of Beck Mack & Oliver LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 800,358 shares of ABT stock, worth $89.9 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares

800,358

Previous 790,911 1.19%

Holding current value

$89.9 Million

Previous $82.2 Million 11.03%

% of portfolio

2.06%

Previous 1.93%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $945,361 - $1.12 Million	9,447 Added 1.19%	800,358 $91.2 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.58 Million - $1.77 Million	-15,718 Reduced 1.95%	790,911 $82.2 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $1.85 Million - $2.05 Million	16,920 Added 2.14%	806,629 $91.7 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.23 Million - $1.5 Million	13,594 Added 1.75%	789,709 $86.9 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $532,484 - $638,891	-5,574 Reduced 0.71%	776,115 $75.2 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $455,626 - $507,663	4,521 Added 0.58%	781,689 $85.2 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $236,822 - $278,754	-2,445 Reduced 0.31%	777,168 $78.7 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $129,661 - $152,113	1,364 Added 0.18%	779,613 $85.6 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $232,998 - $269,768	-2,408 Reduced 0.31%	778,249 $75.3 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.45 Million - $1.75 Million	-14,198 Reduced 1.79%	780,657 $84.8 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $1.2 Million - $1.47 Million	-10,561 Reduced 1.31%	794,855 $94.1 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $1.63 Million - $2 Million	-14,135 Reduced 1.72%	805,416 $113 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $445,057 - $492,363	-3,815 Reduced 0.46%	819,551 $96.8 Million
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $2.47 Million - $2.91 Million	23,329 Added 2.92%	823,366 $95.5 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $5.81 Million - $6.85 Million	-53,389 Reduced 6.26%	800,037 $95.9 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $4.24 Million - $4.62 Million	-40,349 Reduced 4.51%	853,426 $93.4 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $2.04 Million - $2.48 Million	-22,285 Reduced 2.43%	893,775 $97.3 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $5.43 Million - $6.95 Million	-70,869 Reduced 7.18%	916,060 $83.8 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $1.64 Million - $2.4 Million	-26,124 Reduced 2.58%	986,929 $77.9 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $2.61 Million - $2.91 Million	-33,302 Reduced 3.18%	1,013,053 $88 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $3.29 Million - $3.57 Million	-40,180 Reduced 3.7%	1,046,355 $87.5 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $3.05 Million - $3.56 Million	-41,918 Reduced 3.71%	1,086,535 $91.4 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $4.26 Million - $5.15 Million	-64,276 Reduced 5.39%	1,128,453 $90.2 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $2.76 Million - $3.13 Million	-42,111 Reduced 3.41%	1,192,729 $86.3 Million
Q3 2018 Oct 29, 2018	SELL	$60.81 - $73.36 $6.21 Million - $7.5 Million	-102,175 Reduced 7.64%	1,234,840 $90.6 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $2.7 Million - $2.98 Million	-46,874 Reduced 3.39%	1,337,015 $0
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $1.09 Million - $1.23 Million	-19,324 Reduced 1.38%	1,383,889 $0
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $6.7 Million - $7.17 Million	-124,730 Reduced 8.16%	1,403,213 $0
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $73.4 Million - $82 Million	1,527,943	1,527,943 $0

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Account

Beck Mack & Oliver LLC Abbott Laboratories Transaction History